Highlights
1 patent
About
Combined Solution for Nebulization and Inhalation
MEway Pharma develops solutions that combine nebulization and inhalation technologies in order to improve pulmonary drug delivery. The companys UltraFlow Nebulizer is a handheld nebulizer that combines fine particle emission, rapid flow rate, and a breath-actuated mechanism, enabling improved efficacy and a shorter treatment time.
Identity
| Name | MEway Pharma |
|---|---|
| Slug | meway-pharma |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN793tALDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Sep 2022 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ra'anana |
| HQ address | Zarhin Street 13, Ra'anana, Israel |
Web & social
| Website | http://www.meway-pharma.com/ |
|---|---|
| https://www.linkedin.com/company/5107611 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsMedical Devices IndustryHealthcareProviders
Business models
B2B
Tags
inhalationhospitalsdrug-deliverypharma-companiesmedicationmedical-technologiestherapeuticsrespiratorypulmonaryhome-careasthmachildren
Funding
| Total raised | $1.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}